Award
Delivery Order #SPE2D326F6635
Fresenius Kabi Delivery Order for Diphenhydramine Medical Supplies
Buyer
Defense Logistics Agency
Award Amount
$23.37
Ceiling
$23.37
Awarded
February 26, 2026
Period of Performance
Feb 26, 2026 – Feb 27, 2026
Identifier
SPE2D326F6635
NAICS
325411
This award represents a delivery order contract issued to Fresenius Kabi, LLC, a prominent pharmaceutical company specializing in manufacturing and distributing critical medical supplies. The contract procures Diphenhydramine 50 MG/ML vials, a key medication used in various medical treatments and emergency care. This delivery order falls under a larger indefinite delivery contract aimed at ensuring a steady supply of essential pharmaceuticals to the U.S. Department of Defense, thereby supporting military medical readiness and operational effectiveness. The short-term contract covers the supply of this specific pharmaceutical product with a rapid fulfillment timeline. The award was likely made under competitive acquisition principles aligned with the parent contract's procurement strategy. The performance is scheduled for a brief, defined period, underlining the contract's role in timely and precise supply chain management for critical defense pharmaceuticals. This award enhances the existing framework for medical supply continuity to support the health and readiness of U.S. Armed Forces personnel.
Description
4571025538!DIPHENHYDRAMINE 50 MG/ML VIALML